Kayyem Jon Faiz bought 5,000 Inhibrx Biosciences shares at $100 each. For investors tracking insider ownership, the purchase leaves him with 429,360 shares, while the transaction represents about 1.2% of his resulting holding.
Key Highlights
- Kayyem Jon Faiz’s purchase represented about 1.2% of his resulting Inhibrx Biosciences shareholding.
- Transaction code P identifies the September 16 purchase as an open-market transaction.
- Faiz’s reported position after the purchase was 429,360 Inhibrx Biosciences shares.
$100 Per-Share Purchase
Inhibrx Biosciences, Inc. (NASDAQ: INBX) is a biotechnology company. The shares changed hands at $100 per share. The purchase date was 16 September 2026.
Resulting Holding Reaches 429,360 Shares Faiz’s reported ownership after the transaction was 429,360 shares.
The purchase represented about 1.2% of that resulting holding. That percentage is measured against Faiz’s post-transaction position in Inhibrx Biosciences, Inc. The stated ownership figure covers his shares after the purchase.
FAQs
Q: How many Inhibrx Biosciences shares did Kayyem Jon Faiz buy?
A: Kayyem Jon Faiz bought 5,000 Inhibrx Biosciences shares. The transaction price was $100 per share.
Q: What was Kayyem Jon Faiz’s Inhibrx Biosciences holding after the purchase?
A: Faiz’s reported Inhibrx Biosciences holding after the transaction was 429,360 shares. The purchase represented about 1.2% of that resulting position.
Q: When did the Inhibrx Biosciences insider purchase occur?
A: The transaction took place on 16 September 2026. Its transaction code was P, identifying it as an open-market purchase.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.